Vantage Point: The Role of Social Media

Richard Vanderveer
Richard Vanderveer

As we consider the role of social media in healthcare marketing, there is likely no other measure more important than “clout.” A good working definition of this term is “power and influence.” Old-fashioned promotional concepts like “reach” and “frequency” are being replaced by this far more relevant metric.

“Klout,” a four-year-old web service that measures online influence based on “one's ability to drive action,” has Lady Gaga (93) edging out Barack Obama (91) on this 100-point scale. Facebook, Twitter and Google Plus are all included in the determination of how many people you influence, how much you influence them and the power of your network.

As is always the case in promotional measurement, audience segmentation matters. Baby Boomers (born 1946-1964) respond to different elements of clout than do Generation X-ers (1965-1979). Those in Generation Y (1980-1996) show yet another profile. These “Millennials” are key players in social media, since they have seamlessly fused technology into their social lives. Fully 83% of them sleep with their mobile phones turned on in their beds. US teens average 3,146 texts each month, more than 10 texts every waking hour not spent in school.

Key promotional differences between ­generations abound. Generation Y-ers give high value to “Do's” (Have faith in yourself, Be honest) and react poorly to “Don'ts.” Crowd-sourcing is now a way to express personal worth. Conversely, celebrity endorsement is seen as a cop-out resorted to by brands that are so uncool that they need to borrow cool.

Clout. We will find it to be a lot more complicated than a single score, but well worth the time to understand!

Richard Vanderveer is chief solutions officer, rbV3.
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters

What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.

A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.